The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary validation of the Edmonton Symptom Assessment Scale – Acute Leukemia (ESAS-AL) in patients with acute leukemia (AL).
 
Columbe Tricou
No Relationships to Disclose
 
Kenneth Mah
No Relationships to Disclose
 
Carmine Malfitano
No Relationships to Disclose
 
Anne Rydall
No Relationships to Disclose
 
Aaron David Schimmer
Leadership - Trillium Therapeutics
Stock and Other Ownership Interests - Bellicum Pharmaceuticals; Biospecifics Technologies ; Exelixis; GW Pharmaceuticals; NeuroDerm; Ocular Therapeutix; Rigel; Vanda Pharmaceuticals
Honoraria - Fluorinov Pharma; Trillium Therapeutics
Consulting or Advisory Role - Trillium Therapeutics
Research Funding - Aeglea Biotherapeutics; Takeda
Patents, Royalties, Other Intellectual Property - IP rights related to tigecycline
 
Gary Rodin
No Relationships to Disclose
 
Camilla Zimmermann
Honoraria - Teva Innovation Canada
Travel, Accommodations, Expenses - Teva Innovation Canada